20 May 2013
Keywords: novartis, tyzeka, cleared, usa, hbv, swiss, drug
Article | 30 October 2006
Swiss drug major Novartis says that Tyzeka (telbivudine) has been approved in the USA as a new once-a-day oral treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 October 2006
17 May 2013
© 2013 thepharmaletter.com